enVVeno Medical Corporation

NASDAQ:NVNO

5.19 (USD) • At close September 6, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 000.824000000000000.0310000000.0310.030.0420.0830.0310.1750.0280.0390.180.3050.2950.0930.0930
Cost of Revenue 0.1360.1410.1340.1380.1380.1360.130.1330.1330.1290.1220.120.1080.104000000000.9460.4250.2800.0980.13300.1890.2120.3970.1010.1010
Gross Profit -0.136-0.1410.69-0.138-0.138-0.136-0.13-0.133-0.133-0.129-0.122-0.12-0.108-0.1040.0310000000.031-0.915-0.383-0.1970.0310.077-0.1050.039-0.0080.093-0.101-0.008-0.0080
Gross Profit Ratio 000.8370000000000010000001-30.039-9.191-2.36410.44-3.7681-0.0470.305-0.343-0.085-0.0850
Reseach & Development Expenses 2.8253.0522.9812.7984.2143.5952.7972.4923.0731.5521.7821.2251.091.6322.2770.7580.7060.5110.7880.6770.4280.3130.2930.4250.280.240.3490.0430.1850.07300000
General & Administrative Expenses 00000000000000000000000000000000000
Selling & Marketing Expenses 00000000000000000000000000000000000
SG&A 2.4932.313.1632.5512.63.2023.6633.6593.9133.7837.2111.4821.2961.1761.8811.1640.840.9980.9221.1571.5321.3011.2171.1052.9151.2471.6571.6641.0861.051.2280.9591.2241.2240.458
Other Expenses 0000000000000.0010.032000000000000000000000
Operating Expenses 5.3185.3626.1445.3496.8146.7976.466.1516.9865.3358.9922.7072.3852.8084.1581.9221.5461.5091.711.8341.961.6141.511.5293.1951.4882.0061.7071.2711.1221.2280.9591.461.460.583
Operating Income -5.454-5.503-6.278-5.349-6.814-6.797-6.46-6.151-6.986-5.335-8.992-2.707-2.385-2.808-4.158-1.922-1.546-1.509-2.299-1.834-1.96-1.582-1.799-1.488-3.112-1.456-1.929-1.812-1.232-1.131-1.136-1.06-1.232-1.232-0.584
Operating Income Ratio 00-7.61900000000000-133.099000000-50.646-59.055-35.708-37.328-46.884-11.013-64.999-31.746-6.271-3.725-3.588-13.274-13.2730
Total Other Income Expenses Net 0.4980.5110.6290.3040.3010.4050.280.054-0.1130.0050.0050.3130.0010.032-0.216-0.053-0.0810.3460.0080.0190.0140.009-0.320.0190.1841.4890.6240.0040.022-0.024-0.397-0.002-0.254-0.254-0.041
Income Before Tax -4.956-4.992-5.649-5.001-6.474-6.392-6.18-6.097-7.062-5.33-8.988-2.389-2.378-2.773-4.374-1.975-1.627-1.16-2.291-1.815-1.946-1.574-1.782-1.468-5.045-4.747-3.124-2.255-1.249-1.164-1.54-1.076-1.486-1.486-0.624
Income Before Tax Ratio 00-6.85600000000000-139.999000000-50.371-58.487-35.24-60.523-152.824-17.839-80.878-32.188-6.454-5.052-3.643-16.013-16.0120
Income Tax Expense 00.0981.453-0.348-0.34-0.765-0.474-0.0330.07600-0.317-0.007-0.003-00.0520.081-0.0030.5970.0190.0140.009-0.01700.1120.210.1090.4470.0160.0090.0070.0140.0750.0750.004
Net Income -4.956-4.992-5.649-5.001-6.474-5.627-5.706-6.064-7.062-5.33-8.988-2.389-2.378-2.773-4.374-1.975-1.627-1.16-2.291-1.815-1.946-1.574-1.782-1.468-5.045-4.747-3.124-2.255-1.249-1.164-1.54-1.076-1.561-1.561-0.628
Net Income Ratio 00-6.85600000000000-139.999000000-50.371-58.487-35.24-60.523-152.824-17.839-80.878-32.188-6.454-5.052-3.643-16.819-16.8190
EPS -0.31-0.31-0.42-0.45-0.58-0.5-0.6-0.54-0.63-0.47-0.8-0.26-0.28-0.48-1.72-1.37-1.89-1.57-3.19-2.53-3.28-3.21-3.79-3.13-16.21-11.69-8.06-5.82-2.85-2.65-3.51-2.45-6.5-6.5-2.62
EPS Diluted -0.31-0.31-0.42-0.45-0.58-0.5-0.6-0.54-0.63-0.47-0.8-0.26-0.28-0.48-1.72-1.37-1.89-1.57-3.19-2.53-3.28-3.21-3.79-3.13-16.21-11.69-8.06-5.82-2.85-2.65-3.51-2.45-6.5-6.5-2.62
EBITDA -5.318-5.362-6.144-5.515-6.977-7.021-6.566-5.997-6.74-5.206-8.871-2.899-2.278-2.705-4.062-1.771-1.361-1.422-1.597-1.711-1.85-1.482-1.446-1.454-5.084-5.993-3.606-1.779-1.219-1.094-1.095-1.02-1.197-1.197-0.554
EBITDA Ratio 00-7.45600000000000-130.027000000-47.447-47.458-34.906-60.987-192.918-20.589-63.814-31.423-6.067-3.591-3.451-12.898-12.8980